Study of LY3023414 for the Treatment of Recurrent or Persistent Endometrial Cancer

ClinicalTrials.gov ID: NCT02549989

Open the official record

This page only displays public information reproduced from the official ClinicalTrials.gov record NCT02549989. It adds no medical advice, opinions, or eligibility judgments. The official record remains the source of truth for eligibility criteria, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Nov 15, 2026, 3:48 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Single-Arm, Open-Label, Phase II Study of LY3023414 for the Treatment of Recurrent or Persistent Endometrial Cancer

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to determine the effectiveness of LY3023414 in treating the participants type of cancer and to determine the types and severity of side effects caused by treatment with LY3023414.

Study identification

NCT ID: NCT02549989
Recruitment status: Completed
Study type: Interventional
Phase: Phase 2
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Enrollment: 28 participants

Conditions and interventions

Conditions

Interventions

LY3023414 Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: Female
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Sep 2015 (Actual)
Primary completion: Mar 23, 2022 (Actual)
Completion: Mar 23, 2022 (Actual)
Last update posted: Feb 22, 2023

2015 – 2022

United States locations

U.S. sites: 6
U.S. states: 2
U.S. cities: 6

Facility	City	State	ZIP	Site status
Memorial Sloan Kettering at Basking Ridge	Basking Ridge	New Jersey	07920	—
Memorial Sloan Kettering Monmouth	Middletown	New Jersey	07748	—
Memorial Sloan Kettering Commack	Commack	New York	11725	—
Memorial Sloan Kettering Westchester	Harrison	New York	10604	—
Memorial Sloan Kettering Cancer Center	New York	New York	10065	—
Memorial Sloan Kettering Nassau	Uniondale	New York	11553	—

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT02549989, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Feb 22, 2023 · Synced Nov 15, 2026